Skip to main content

Best Vitelliform Macular Dystrophy

  • Chapter
  • First Online:
Macular Dystrophies

Abstract

Best vitelliform macular dystrophy (Best VMD) also called Best disease is a clinically heterogeneous and pleomorphic disease, in most cases showing an autosomal dominant pattern of inheritance with extremely variable penetrance and expressivity. In most cases, patients harbour heterozygous mutation in BEST1 gene, coding for a protein acting as a Ca2+-activated Cl channel. In most cases the disease begins in the first decade of life. Five stages based on fundus examination have been described: each stage is also characterized by typical spectral-domain optical coherence tomography (SD-OCT) and fundus autofluorescence (FAF) signs. BEST1 gene is also related to other diseases, called bestrophinopathies.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 159.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 159.00
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Best F. Uber eine hereditare maculaafektion; Beitrage zur verergslehre. Zschr Augenheilkd. 1905;13:199–212.

    Google Scholar 

  2. Stone EM, Nichols BE, Streb LM, Kimura AE, Sheffield VC. Genetic linkage of vitelliform macular degeneration (Best’s disease) to chromosome 11q13. Nat Genet. 1992;1(4):246–50.

    Article  CAS  PubMed  Google Scholar 

  3. Petrukhin K, Koisti MJ, Bakall B, Li W, Xie G, Marknell T, et al. Identification of the gene responsible for Best macular dystrophy. Nat Genet. 1998;19(3):241–7.

    Article  CAS  PubMed  Google Scholar 

  4. Sun H, Tsunenari T, Yau KW, Nathans J. The vitelliform macular dystrophy protein defines a new family of chloride channels. Proc Natl Acad Sci U S A. 2002;99:4008–13.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  5. Boon CJ, Klevering BJ, Leroy BP, Hoyng CB, Keunen JE, den Hollander AI. The spectrum of ocular phenotypes caused by mutations in the BEST1 gene. Prog Retin Eye Res. 2009;28(3):187–205.

    Article  CAS  PubMed  Google Scholar 

  6. Kaufman SJ, Goldberg MF, Orth DH, Fishman GA, Tessler H, Mizuno K. Autosomal dominant vitreoretinochoroidopathy. Arch Ophthalmol. 1982;100:272–8.

    Article  CAS  PubMed  Google Scholar 

  7. Lotery AJ, Munier FL, Fishman GA, Weleber RG, Jacobson SG, Affatigato LM, et al. Allelic variation in the VMD2 gene in best disease and age-related macular degeneration. Invest Ophthalmol Vis Sci. 2000;41(6):1291–6.

    CAS  PubMed  Google Scholar 

  8. Bakall B, Radu RA, Stanton JB, Burke JM, McKay BS, Wadelius C, et al. Enhanced accumulation of A2E in individuals homozygous or heterozygous for mutations in BEST1 (VMD2). Exp Eye Res. 2007;85(1):34–43.

    Article  CAS  PubMed  Google Scholar 

  9. Gass JD. A clinicopathologic study of a peculiar foveomacular dystrophy. Trans Am Ophthalmol Soc. 1974;72:139–56.

    PubMed Central  CAS  PubMed  Google Scholar 

  10. Patrinely JR, Lewis RA, Font RL. Foveomacular vitelliform dystrophy, adult type: a clinicopathologic study including electron microscopic observations. Ophthalmology. 1985;92:1712–8.

    Article  CAS  PubMed  Google Scholar 

  11. Davidson AE, Millar ID, Urquhart JE, Burgess-Mullan R, Shweikh Y, Parry N, et al. Missense mutations in a retinal pigment epithelium protein, bestrophin-1, cause retinitis pigmentosa. Am J Hum Genet. 2009;85(5):581–92.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  12. Burgess R, Millar ID, Leroy BP, Urquhart JE, Fearon IM, De Baere E, et al. Biallelic mutation of BEST1 causes a distinct retinopathy in humans. Am J Hum Genet. 2008;82(1):19–31.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  13. Manes G, Meunier I, Avila-Fernndez A, Banfi S, Le Meur G, Zanlonghi X, et al. Mutations in IMPG1 cause vitelliform macular dystrophies. Am J Hum Genet. 2013;93(3):571–8.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  14. Nordstrom S, Barkman Y. Hereditary macular degeneration (HMD) in 246 cases traced to one gene-source in central Sweden. Hereditas. 1977;84:163–76.

    Article  CAS  PubMed  Google Scholar 

  15. Deutman AF, Hoyng CB. Macular dystrophies. In: Ryan SJ, editor. Retina. 3rd ed. St. Louis: Mosby; 2001. p. 1210–57.

    Google Scholar 

  16. Thorburn W, Nordström S. EOG in a large family with hereditary macular degeneration. (Best’s vitelliform macular dystrophy) identification of gene carriers. Acta Ophthalmol (Copenh). 1978;56(3):455–64.

    Article  CAS  Google Scholar 

  17. Marmor MF. “Vitelliform” lesions in adults. Ann Ophthalmol. 1979;11(11):1705–12.

    CAS  PubMed  Google Scholar 

  18. Querques G, Zerbib J, Georges A, Massamba N, Forte R, Querques L, et al. Multimodal analysis of the progression of Best vitelliform macular dystrophy. Mol Vis. 2014;20:575–92.

    PubMed Central  PubMed  Google Scholar 

  19. Mohler CW, Fine SL. Long-term evaluation of patients with Best’s vitelliform dystrophy. Ophthalmology. 1981;88:688–92.

    Article  CAS  PubMed  Google Scholar 

  20. Querques G, Regenbogen M, Quijano C, Delphin N, Soubrane G, Souied EH. High definition optical coherence tomography features in vitelliform macular dystrophy. Am J Ophthalmol. 2008;146:501–7.

    Article  PubMed  Google Scholar 

  21. Spaide RF, Curcio CA. Anatomical correlates to the bands seen in the outer retina by optical coherence tomography: literature review and model. Retina. 2011;31(8):1609–19.

    Article  PubMed Central  PubMed  Google Scholar 

  22. Querques G, Zerbib J, Santacroce R, Margaglione M, Delphin N, Querques L, et al. The spectrum of subclinical Best vitelliform macular dystrophy in subjects with mutations in BEST1 gene. Invest Ophthalmol Vis Sci. 2011;52(7):4678–84.

    Article  CAS  PubMed  Google Scholar 

  23. Querques G, Zerbib J, Santacroce R, Margaglione M, Delphin N, Rozet JM, et al. Functional and clinical data of Best vitelliform macular dystrophy patients with mutations in the BEST1 gene. Mol Vis. 2009;15:2960–72.

    PubMed Central  CAS  PubMed  Google Scholar 

  24. Querques G, Regenbogen M, Soubrane G, Souied EH. High-resolution spectral domain optical coherence tomography findings in multifocal vitelliform macular dystrophy. Surv Ophthalmol. 2009;54(2):311–6.

    Article  PubMed  Google Scholar 

  25. Arnold JJ, Sarks JP, Killingsworth MC, Kettle EK, Sarks SH. Adult vitelliform macular degeneration: a clinicopathological study. Eye (Lond). 2003;17(6):717–26.

    Article  CAS  Google Scholar 

  26. Maruko I, Iida T, Spaide RF, Kishi S. Indocyanine green angiography abnormality of the periphery in vitelliform macular dystrophy. Am J Ophthalmol. 2006;141(5):976–8.

    Article  PubMed  Google Scholar 

  27. Deutman AF. Electro-oculography in families with vitelliform dystrophy of the fovea. Detection of the carrier state. Arch Ophthalmol. 1969;81(3):305–16.

    Article  CAS  PubMed  Google Scholar 

  28. Meunier I, Sénéchal A, Dhaenens CM, Arndt C, Puech B, Defoort-Dhellemmes S, et al. Systematic screening of BEST1 and PRPH2 in juvenile and adult vitelliform macular dystrophies: a rationale for molecular analysis. Ophthalmology. 2011;118(6):1130–6.

    Article  PubMed  Google Scholar 

  29. Blodi CF, Stone EM. Best’s vitelliform dystrophy. Ophthalmic Paediatr Genet. 1990;11(1):49–59.

    CAS  PubMed  Google Scholar 

  30. Cross HE, Bard L. Electro-oculography in Best’s macular dystrophy. Am J Ophthalmol. 1974;77(1):46–50.

    Article  CAS  PubMed  Google Scholar 

  31. Caldwell GM, Kakuk LE, Griesinger IB, Simpson SA, Nowak NJ, Small KW, et al. Bestrophin gene mutations in patients with Best vitelliform macular dystrophy. Genomics. 1999;58(1):98–101.

    Article  CAS  PubMed  Google Scholar 

  32. Wabbels B, Preising MN, Kretschmann U, Demmler A, Lorenz B. Genotype-phenotype correlation and longitudinal course in ten families with best vitelliform macular dystrophy. Graefes Arch Clin Exp Ophthalmol. 2006;244(11):1453–66.

    Article  CAS  PubMed  Google Scholar 

  33. Fishman GA, Baca W, Alexander KR, Derlacki DJ, Glenn AM, Viana M. Visual acuity in patients with best vitelliform macular dystrophy. Ophthalmology. 1993;100(11):1665–70.

    Article  CAS  PubMed  Google Scholar 

  34. Booij JC, Boon CJ, van Schooneveld MJ, ten Brink JB, Bakker A, de Jong PT, et al. Course of visual decline in relation to the BEST1 genotype in vitelliform macular dystrophy. Ophthalmology. 2010;117(7):1415–22.

    Article  PubMed  Google Scholar 

  35. Leu J, Schrage NF, Degenring RF. Choroidal neovascularisation secondary to Best’s disease in a 13-year-old boy treated by intravitreal bevacizumab. Graefes Arch Clin Exp Ophthalmol. 2007;245(11):1723–5.

    Article  PubMed  Google Scholar 

  36. Querques G, Bocco MC, Soubrane G, Souied EH. Intravitreal ranibizumab (Lucentis) for choroidal neovascularization associated with vitelliform macular dystrophy. Acta Ophthalmol. 2008;86(6):694–5.

    Article  PubMed  Google Scholar 

  37. Boon CJ, Theelen T, Hoefsloot EH, van Schooneveld MJ, Keunen JE, Cremers FP, et al. Clinical and molecular genetic analysis of best vitelliform macular dystrophy. Retina. 2009;29(6):835–47.

    Article  PubMed  Google Scholar 

  38. Burgess DB, Olk RJ, Uniat LM. Macular disease resembling adult foveomacular vitelliform dystrophy in older adults. Ophthalmology. 1987;94(4):362–6.

    Article  CAS  PubMed  Google Scholar 

  39. Boon CJ, Klevering BJ, Hoyng CB, Zonneveld-Vrieling MN, Nabuurs SB, Blokland E, et al. Basal laminar drusen caused by compound heterozygous variants in the CFH gene. Am J Hum Genet. 2008;82(2):516–23.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  40. Gass JD, Chuang EL, Granek H. Acute exudative polymorphous vitelliform maculopathy. Trans Am Ophthalmol Soc. 1988;86:354–66.

    PubMed Central  CAS  PubMed  Google Scholar 

  41. Eksandh L, Adamus G, Mosgrove L, Andréasson S. Autoantibodies against bestrophin in a patient with vitelliform paraneoplastic retinopathy and a metastatic choroidal malignant melanoma. Arch Ophthalmol. 2008;126(3):432–5.

    Article  CAS  PubMed  Google Scholar 

  42. Yardley J, Leroy BP, Hart-Holden N, Lafaut BA, Loeys B, Messiaen LM, et al. Mutations of VMD2 splicing regulators cause nanophthalmos and autosomal dominant vitreoretinochoroidopathy (ADVIRC). Invest Ophthalmol Vis Sci. 2004;45(10):3683–9.

    Article  PubMed  Google Scholar 

  43. Burgess R, MacLaren RE, Davidson AE, Urquhart JE, Holder GE, Robson AG, et al. ADVIRC is caused by distinct mutations in BEST1 that alter pre-mRNA splicing. J Med Genet. 2009;46(9):620–5.

    Article  CAS  PubMed  Google Scholar 

  44. Reddy MA, Francis PJ, Berry V, Bradshaw K, Patel RJ, Maher ER, Kumar R, Bhattacharya SS, Moore AT. A clinical and molecular genetic study of a rare dominantly inherited syndrome (MRCS) comprising of microcornea, rod-cone dystrophy, cataract, and posterior staphyloma. Br J Ophthalmol. 2003;87(2):197–202.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Giuseppe Querques MD, PhD .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Zerbib, J., Souied, E.H., Querques, G. (2016). Best Vitelliform Macular Dystrophy. In: Querques, G., Souied, E. (eds) Macular Dystrophies. Springer, Cham. https://doi.org/10.1007/978-3-319-26621-3_1

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-26621-3_1

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-26619-0

  • Online ISBN: 978-3-319-26621-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics